Flyer

Archives of Clinical Microbiology

  • ISSN: 1989-8436
  • Journal h-index: 24
  • Journal CiteScore: 8.01
  • Journal Impact Factor: 7.55
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Open J Gate
  • Genamics JournalSeek
  • The Global Impact Factor (GIF)
  • Open Archive Initiative
  • China National Knowledge Infrastructure (CNKI)
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Proquest Summons
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • Scimago Journal Ranking
  • Secret Search Engine Labs
  • ResearchGate
  • International Committee of Medical Journal Editors (ICMJE)
Share This Page

Mini Review - (2016) Volume 7, Issue 5

Current Epidemiology of Non-beta-Lactam Antibiotics-resistance in Escherichia coli from Animal Origins in Tunisia: A Paradigm of Multidrug Resistance

Abbassi Mohamed Salah1*, Debbichi Najwa1, Mahrouki Sihem1 and Hammami Salah2

1Univérsité de Tunis El Manar, Institut de la Recherche Vétérinaire de Tunisie, Laboratoire de la recherche bactériologique, Bab Saadoun, Tunis 1006, Tunisie

2École Nationale de Médecine Vétérinaire de Sidi Thabet, Tunisie

Corresponding Author:

Abbassi Mohamed Salah
Institute of Veterinary Research of Tunisia
20 Street Jebel Lakhdhar, Bab Saadoun
Tunis 1006, Tunisia
Tel: 00216 71 561 070
Fax: 00216 71 569 692
E-mail: salahtoumi_mohamed@yahoo.com

Received Date: September 06, 2016; Accepted Date: September 23, 2016; Published Date: September 30, 2016

Citation: Salah AM, Najwa D, Sihem M, et al. Current Epidemiology of Non-β-Lactam Antibiotics-Resistance in Escherichia coli from Animal Origins in Tunisia: A Paradigm of Multidrug Resistance. Arch Clin Microbiol. 2016, 7:5. doi:10.4172/1989-8436.100059

Copyright: © 2016 Salah AM et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Archives of Clinical Microbiology

Abstract

Worldwide, resistance to antibiotics is a major health problem. Nowadays, multiples lines of evidence confirmed that food, in particular poultry products, may acts as reservoir of antibiotic-resistant bacteria or genetic elements encoding antibiotic resistance. Commensal Escherichia coli colonizing animals designated to human consummation (poultry, bovine, pork) often harbors mobile genetic elements that can be transferred in vivo to infectious pathogens. In addition, antibiotic resistant E. coli can be easily transferred to human via food chain. The objective of this work was to review the published data on the prevalence of antibiotic resistance and their genetic supports in E. coli of animal origins in Tunisia.

Keywords

Antibiotic-resistance, Escherichia coli, animal, Tunisia

Introduction

Antimicrobial resistance (AMR) is one of the most serious public health concerns of the twenty-first century. It is of particular concern the phenomenon of resistance carried out by some Gram- positive and negative bacteria such as methicillinresistant Staphylococcus aureus, glycopeptides-resistant Enterococcus faecium/Enterococcus faecalis and beta-lactamresistant Enterobacteriaceae [1]. AMR has been largely limited to bacteria from human clinical setting; however, antibioticresistant bacteria of animal origin have been increasingly reported worldwide [2]. Consequently, foods of animal origin are considered as reservoirs of antibiotic-resistant zoonotic bacteria. Nowadays, most experts agree that the contribution from food animals is a concern and many evidences seem to indicate that the importance of the food-animal reservoir is larger than we estimated a decade ago. Worldwide, beta-lactam-resistant Escherichia coli producing Extended Spectrum Beta-Lactamases (ESBLs), cephalosporinases or carbapenemases have been increasingly reported from food animals as well as from many wildlife species [3,4]. In Tunisia, high frequencies of antibiotic resistant E. coli from human as well as from animal or foods of animal origin have been increasingly reported during the last decade. Recently we have published a review reporting the occurrence of ESBL-producing E. coli from animal and foods of animal origin [5] highlighting the importance of this worrisome phenomenon in Tunisia. However, studies on resistance to other critically important antimicrobial families are also of interest to improve our knowledge about E. coli of animal origins. This might be useful not only for Tunisian health authorities and politician deciders but also for neighbour countries especially European countries that we share with them large economic exchanges including food products. Therefore, in this work we aimed to review the published data on the prevalence of AMR (other than beta-lactams resistance) and their genetic supports in E. coli of animal origins in Tunisia.

The level of the AMR problem in Tunisia

Aminoglycosides, tetracyclines, quinolones, trimethoprim, and sulfonamides are mainly used in the treatment of E. coli infections in humans and animals [6]. Therefore, resistance to these antibiotics is of great concern. Nowadays, increasing rates of resistance are reported worldwide in Enterobacteriaceae especially in E. coli regardless of their animal or human origin [7,8]. In this context, all reported results about antibiotic susceptibility of E. coli isolates from animal sources in Tunisia showed high rates of resistance to the above-mentioned antibiotics [9,10]. Similarly to the global trend, particular high rates of resistance were observed against tetracycline, streptomycin, trimethoprim/sulfonamides, sulfonamides, and nalidixic acid. In unpublished survey in our Institute of Veterinary Research of Tunisia, we found that the level of resistance to different antimicrobials significantly varied according to the source of the isolates. E. coli isolates from poultry meats and faeces have the highest resistance rates than those from bovine and sheep. This finding might be a consequence of the selective pressures imposed by antimicrobial use in different food animal production and processing environments. In addition, the high levels of resistance in poultry may be partly due to the specific practices in avian industry, in which antimicrobials for disease control and prevention are overused [11,12].

Tetracycline resistance

Tetracycline resistance has been observed in 43% [13], 89% [9], and 95.2% [10] of E. coli isolates from food samples of animal origin (poultry, sheep, beef) (Table 1). This finding is in agreement to other studies reporting high rates of tetracyclineresistant E. coli from animal origins, especially in pig and chicken, ranging from 17.1 % (cattle) to 70.6 % (pigs) in different European countries (France, Italy, UK, Germany, Ireland, Greece) [8,14] and reaching 89.63 % (poultry) in China [15]. This finding might be explained by the fact that tetracyclines, including chlortetracycline and minocycline, have been amongst the oldest antibiotics and have been used for growth promotion for poultry [16]. In addition, its efficacy, low cost, and the lack of side effects make it the most popularly used antibiotic in livestock farming. Its widespread and imprudent use caused a high prevalence of tetracycline-resistant bacteria nowadays. Resistance to tetracycline can occur by various mechanisms including active efflux of tetracycline, the production of ribosomal protection proteins, decreased drug permeability, target mutation, and enzymatic degradation of the antibiotics [17]. However, active efflux of tetracycline predominates in Enterobacteriaceae, and at least 26 tet-type genes have been reported to encode efflux-pumps [17]. Amongst those determinants, tetA and tetB alleles have been mainly reported to predominate in E. coli regardless their origin, followed by tetC gene [15,18,19]. It can be assumed that the tetA gene can be spread more easily in the environment than other tetB and tetCgenes. Similarly, in the Tunisian studies, tetracycline-resistant E. coli mainly harboured tetA and tetB genes, being found in ranges of 37.9 % to 77.5% and 16.4% to 32%, respectively [9,10,13].

Antibiotic agent Rates of antibiotic resistance (%) Detected genes
Tunisia Worldwide
Tetracycline 43-95.2 17.1-89.63 tetA, tetB, tetC
Trim/sulf 29-80 9.0-70.6 sul1, sul2, sul3, dfrA1, dfrA17, dfrA5, dfrA12
Streptomycin 29-78 17.1-70.1 aadA1, aadA2, aadA5
Nalidixic acid 33 - 72.3 22-41 *gyrA mutations:Ser83Leu, Asp87Gly, Asp87Asn Asp87Tyr
*parC mutations: Ser80Ile, Glu84Gly, Ser80Arg
Ciprofloxacin 7.0-19.9 10.9-62.5 qnrS1, qnrB5, qnrB19
Gentamicin 0-03 0-10 aac(3)-II
Kanamycin 40 - aph(3′)-Ia ; aac(6′)-Ib-cr

Table 1: Frequencies and genetic supports of antimicrobial resistance of E. coli of animal origins in Tunisia

Resistance to aminosides and trimethoprim/ sulphonamides

Resistance to streptomycin, the combination trimethoprim/ sulfamethoxazole, and to sulfonamides are also high in E. coli of animal origins in our country. Indeed, resistance frequencies of 29% to 78%, 29% to 80%, and 39% to 87% have been reported for streptomycin, trimethorprim/sulfamethoxazole (SXT), and sulfonamide, respectively [9,10,13]. These high frequencies are very similar to reported results worldwide (SXT: 9.0% - 70.6%; Streptomycin: 17.1% - 70.1%) [8,14,15]. Moreover, worldwide, in each studied E. coli collection, frequencies of resistance to these three antibiotics are mainly very close, indicating that E. coli isolates are concurrently resistant against these antibiotics. According to genetic point of view, these results are expected since genes encoding streptomycin, trimethoprim, and sulfonamides-resistance are usually co-located on the same genetic vehicle such as integrons, plasmids and transposons [20]. Sulfonamide resistance in Gram-negative bacilli generally rises from the presence of the sul1, sul2, and or sul3 genes [21,22]. Historically, sul1 and sul2 genes were the most prevalent ones in E. coli from animal and human origin, and sul3 gene scarcely detected. However, recently in Tunisia and in other part of the world, the sul3 gene has been emerged as an important determinant encoding sulfonamide resistance. This finding was attributed to another genetic phenomenon linked to a specific genetic rearrangement in the structure of the typical class 1 integron. Indeed, recently, many studies highlighted the increasing reports of lack of the sul1 gene from the 3’-CS (qacΔEsul1) of class 1 integron and its replacement by sul3 gene. More importantly, the sul3 gene was found in a transposase-like sequence, qacH-IS440-sul3-orf1-IS26 [23,24] that might have contributed to the maintenance and further spread of sul3 in E. coli isolates.

Resistance to streptomycin was mainly encoded by aadA type gene variants (aadA1, aadA2, aadA5) rarely by aadB alleles as reported in Tunisia and in others countries [9,10,13,25-27]. Interestingly, the different aadA alleles have been showed genetically linked to various dfrA alleles (dfrA1, dfrA17, dfrA5, dfrA12) on class 1 integron. This finding explains in part the close rates of resistance against trimethorprim and streptomycin in E. coli isolates reported by many studies [8-10,14,15]. Moreover, and considering the occurrence of both these genes (dfrA+aadA) on class 1 integron with 3’-CS containing sul1 or sul3 genes; such strains are therefore also resistant to sulfonamide [28]. Kanamycin-resistance has been also reported, with moderate level (0-40%) and encoded by aph(3′)-Ia ; aac(6′)- Ib-cr genes. In contrast to aforementioned rates of antimicrobial resistance, rate of gentamicin resistance was very low, being less than 2 % and mainly encoded by the aac(3)-II gene [9,10,13,25,26,29].

Resistance to fluoroquinolones

In Tunisia, non cephalosporins-resistant isolates showed resistance to nalidixic acid, which varied from 33% to 72.3%, and ciprofloxacin-resistance ranging from 7% to 19.9% [9,10,13]. In the world, the prevalence of fluoro-quinolones resistance in E. coli from poultry has been increasingly reported. The mechanisms attributed to quinolones resistance are principally related to mutations in the quinolone resistance determinants regions (QRDR) of gyrA and parC genes [30]. Ser83Leu, Asp87Gly, Asp87Asn and Asp87Tyr substitutions in GyrA protein have been reported, and Ser80Ile, Glu84Gly and Ser80Arg in ParC protein [26,31]. Plasmid-mediated-quinolone resistance (PMQR) was also found to contribute to the increase of quinolone resistance among E. coli isolates [30]. qnrS1, qnrB5 and qnrB19 genes have been reported respectively in chicken samples and faecal samples from healthy dog in Tunisia [29,31]. The aac(6’)-Ib-cr gene, which encodes a variant of the widespread aminoglycoside acetyltransferase ACC(6’)-Ib was also detected in chicken and poultry meat samples [10,29].

Conclusions

Worldwide, a global analysis showed high resistance rates against tetracycline, trimethorprim/sulfamethoxazole, streptomycin and quinolones antibiotics. E. coli from pig and poultry were the most resistant ones. This finding is linked to the specific production systems of pig and poultry, where thousands of organisms are assembled in crowded limited space. In such industrialized environments, animals are stressed and highly susceptible to bacterial and viral infections. Consequently, and to overcome economic losses, application of antimicrobial substances is common in pig and poultry farms. Therefore, these antibiotic-rich environments become ideal settings of crosstransmission of resistant E. coli isolates and genetic elements encoding antibiotic resistance (integrons, plasmids). E. coli of animal and food-producing animals in Tunisia seems to be in the global way of acquiring multi-drug-resistance. The high rates of resistance to tetracycline, streptomycin, quinolones/ fluoroquinolones and trimethoprim/sulfamethoxazole are compared to the worldwide situation.

Conflict of Interest

All authors have contributed equally to the realization of this work. None of the contributing authors has any conflict of interests relevant to the subject matter or materials discussed in the manuscript. No funding or other financial support was received.

17162

References

  1. Fernández J, Bert F, Nicolas-Chanoine MH (2016) The challenges of multidrug resistance in hepatology. J Hepatol.
  2. Silbergeld EK, Graham J, Price LB (2008). Industrial food animal production, antimicrobial resistance, and human health. Annu Rev Public Health 29:151-169.
  3. Sallem RB, Slama KB, Sáenz Y, Rojo-Bezares B, Estepa V, et al.(2012) Prevalence and characterization of extended-spectrum beta-Lactamase (ESBL) and CMY-2-producing Escherichia coli isolates from healthy food-producing animals in Tunisia. Food Patho Dis 9: 1147-1142.
  4. Ewers C, Bethe A, Semmler T, Guenther S, Wieler LH (2012) Extended-spectrum β-lactamase-producing and AmpC-producing Escherichia coli from livestock and companion animals, and their putative impact on public health: a global perspective. ClinMicrobiolInfec 18: 646-655.
  5. Mahrouki S, Hammami S, Mansouri R, Abbassi MS (2015) Overview of ESBL-producing Escherichia coli of animal origin in Tunisia: In the way of the global spread of CTX-M β-Lactamases. Arch ClinMicrobiol 6: 4.
  6. Hammerum AM, Heuer OE (2009) Human health hazards from antimicrobial-resistant Escherichia coli of animal origin. Clin Infect Dis 48: 916-921.
  7. Horner CS, Abberley N, Denton M, Wilcox MH (2013) Surveillance of antibiotic susceptibility of Enterobacteriaceae isolated from urine samples collected from community patients in a large metropolitan area, 2010-2012. Epidemiol Infect 9:1-5.
  8. De Jong A, Thomas, V, Simjee S, Godinho K, Schiessl B (2012) Pan-European monitoring of susceptibility to human-use antimicrobial agents in enteric bacteria isolated from healthy food-producing animals. J AntimicrobChemother67: 638-651.
  9. Soufi L, Abbassi MS, Saenz Y, Vinué L, Somalo S, et al. (2009) Prevalence and diversity of integrons and associated resistance genes in Escherichia coli isolates from poultry meat in Tunisia. Food Patho Dis. 6: 1067-1073.
  10. Soufi L, Saenz Y, Vinué L, Abbassi MS, Ruiz E, et al.(2011) Escherichia coli of poultry food origin as reservoir of sulphonamide resistance genes and integrons. Int J AntimicrobAgents 144: 497-502.
  11. Apata DF (2009) Antibiotic resistance in poultry. Int J PoultSci 8:404-408.
  12. Gyles CC (2008) Antimicrobial resistance in selected bacteria from poultry. Anim Health Res Rev 9:149-158.
  13. Jouini A, Ben Slama K, Saenz Y, Klibi N, Costa D, et al. (2009). Detection of multiple-antimicrobial resistance and characterization of the implicated genes in Escherichia coli isolates from foods of animal origin in Tunis. J FoodProt 72:1082-1088.
  14. Gousia P, Economou V, Sakkas H, Leveidiotou S,Papadopoulou C (2011) Antimicrobial resistance of major foodborne pathogens from major meat products. FoodbornePathog Dis 8:27-38.
  15. Zhang T, Wang CG, Lv JC, Wang RS, Zhong XH (2012). Survey on tetracycline resistance and antibiotic-resistant genotype of avian Escherichia coli in North China. PoultSci 91:2774-2777.
  16. Chopra I, Roberts M (2001). Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. MicrobiolMolBiol Rev 65: 232-260.
  17. Roberts MC (2005) Update on acquired tetracycline resistance genes. FEMS MicrobiolLett 245:195-203.
  18. Bryan A, Shapir N, Sadowsky MJ (2004) Frequency and distribution of tetracycline resistance genes in genetically diverse, non-selected, and nonclinical Escherichia coli strains isolated from diverse human and animal sources. Appl Environ Microbiol 70:2503-2507.
  19. Koo HJ, Woo GJ (2011) Distribution and transferability of tetracycline resistance determinants in Escherichia coli isolated from meat and meat products. Int J Food Microbiol145:407-413.
  20. Kiiru J, Butaye P, Goddeeris BM, Kariuki S (2013). Analysis for prevalence and physical linkages amongst integrons, ISEcp1, ISCR1, Tn21 and Tn7 encountered in Escherichia coli strains from hospitalized and non-hospitalized patients in Kenya during a 19-year period (1992–2011). BMC Microbiol 13:109.
  21. Hammerum AM, Sandvang D, Andersen SR, Seyfarth AM, Porsbo LJ, et al (2006) Detection of sul1, sul2 and sul3 in sulphonamide resistant Escherichia coli isolates obtained from healthy humans, pork and pigs in Denmark. Int J Food Microbiol 106:235-237.
  22. Trobos M, Jakobsen L, Olsen KE, Frimodt-Møller N, Hammerum AM, et al. (2008) Prevalence of sulphonamide resistance and class 1 integron genes in Escherichia coli isolates obtained from broilers, broiler meat, healthy humans and urinary infections in Denmark. IntJ Antimicrob Agents 32:367-369.
  23. Perreten V, Boerlin P (2003) A new sulfonamide resistance gene (sul3) in Escherichia coli is widespread in the pig population of Switzerland. Antimicrob Agent Chemother 47:1169-1172.
  24. Antunes P, Machado J, Peixe L (2007) Dissemination of sul3-containing elements linked to class 1 integrons with an unusual 3' conserved sequence region among Salmonella isolates. Antimicrob Agents Chemother 51:1545-1548.
  25. Ben Slama K, Jouini A, Ben Sallem R, Somalo S, Sáenz Y, et al. (2010) Prevalence of broad-spectrum cephalosporin-resistant Escherichia coli isolates in food samples in Tunisia, and characterization of integrons and antimicrobial resistance mechanisms implicated. Inter J Food Microbiol 137:281-286.
  26. Jouini A, Vinue L, Ben Slama K, Sáenz Y, Klibi N, et al.(2007) Characterization of CTX-M and SHV extended-spectrum β-lactamases and associated resistance genes in Escherichia coli strains of food samples in Tunisia. J AntimicrobChemother 60:1137-1141.
  27. Zhang XY, Ding LJ, Yue J (2009) Occurrence and characteristics of class 1 and class 2 integrons in resistant Escherichia coli isolates from animals and farm workers in northeastern China. Microb Drug Resist 15:223-228.
  28. Wu S, Dalsgaard A, Hammerum AM, Porsbo LJ, Jensen LB (2010) Prevalence and characterization of plasmids carrying sulfonamide resistance genes among Escherichia coli from pigs, pig carcasses and human. Acta Vet Scand 52: 47.
  29. Mnif B, Ktari S, Rhimi FM, Hammami A (2012) Extensive dissemination of CTX-M-1- and CMY-2-producing Escherichia coli in poultry farms in Tunisia. Letter ApplMicrob 55: 407-413.
  30. Poirel L, Cattoir V, Nordmann P (2012) Plasmid-mediated quinolone resistance; interactions between human, animal, and environmental ecologies. Front Microbiology 3: 24.
  31. Sallem RB, Gharsa H, Slama KB, Rojo-Bezares B, Estepa V (2013) First detection of CTX-M-1, CMY-2, and qnrB19 resistance mechanisms in faecal Escherichia coli isolates from healthy pets in Tunisia. Vector Borne Zoonotic Dis 13:98-102.